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Abstract
Background: The supply of long-chain polyunsaturated fatty acids via the placenta is interrupted
in premature infants, making them exclusively dependent on breast milk, which varies in fatty acid
(FA) concentrations depending on the mother's diet.
Objective: To in a longitudinal study explore the relation between FA status in mothers and
infants from an unselected cohort of prematures, not requiring intensive care.
Design: Breast milk and mothers' and infants' plasma phospholipid FA concentrations from birth
to 44 weeks of gestational age were analysed and compared with mothers' food intake, assessed
using a 3-day diary. Fatty acids were analysed by capillary gas-liquid chromatography.
Results: The energy intake was low in 75% of mothers, and 90% had low intake of essential FAs
(EFAs). Dietary linoleic acid (LA, 18:2w6), but not w3 FAs, correlated to concentrations in breast
milk. Infants' plasma and breast milk correlated for arachidonic (AA, 20:4w6), eicosapentaenoic
(EPA, 20:5w3) and docosahexaenoic (DHA, 22:6w3) acids. A high concentration of mead acid
(20:3w9) in the infants at birth correlated negatively to the concentrations of LA, AA and w3 FAs.
Infants of mothers who stopped breastfeeding during the study period showed decreased DHA
concentrations and increased w6/w3 ratios, with the opposite FA pattern seen in the mothers'
plasma.
Conclusion: Although dietary w3 FAs were insufficient in an unselected cohort of mothers of
premature infants, breastfeeding resulted in increased levels of DHA in the premature infants at
the expense of the mothers, suggesting a general need to increase dietary w3 FAs during pregnancy
and lactation.
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Introduction
The importance of lipids for growth and development of
the central nervous system (CNS) was addressed by Wid-
dowson in 1968 [1], but has been given more attention
during the latest decades [2-4]. During the last trimester of
pregnancy, a substantial number of essential fatty acids
(EFAs), predominantly the long-chain polyunsaturated
fatty acids (LCPUFAs) are transferred from the mother to
the foetus [5,6]. During this time and in the early neonatal
period, rapid synthesis of brain tissue, with cellular differ-
entiation and active synaptogenesis, has a special need for
docosahexaenoic (DHA) (22:6w3), eicosapentaenoic
(EPA) (20:5w3) and arachidonic (AA) (20:4w6) acids.
From 26 weeks of gestation until term 80% of the brain
DHA accrues in the foetus [3], and recent research has also
stressed the importance of DHA for normal development
of the glial cell [7,8]. This challenge is met by increased
extraction of LCPUFAs via the placenta, and also by some
synthesis from the precursors linoleic acid (LA) (18:2w6)
and α-linolenic acid (ALA) (18:3w3) [9,10]. The LCPUFAs
transferred from mother to foetus in the last trimester and
during the early weeks of life have been calculated to be
50 mg/kg/day for w3 and 400 mg/kg/day for w6 FAs [11].
In premature infants this supply is interrupted and the
infant is exclusively dependent on breast milk, which var-
ies regarding FA content, mainly depending on the
mother's diet [12-14]. Human breast milk contains EFAs
of the w6 and the w3 series, while until recently most for-
mulas have not been supplemented with LCPUFAs [15].
Breast milk is generally considered the gold standard of
infant feeding despite well-documented variations related
to the mother's diet and her lipid stores [9,16-18], and it
is not clear whether the extended requirements of the pre-
mature infant are met. Some authors report a higher con-
centration of LCPUFAs in the milk of mothers giving birth
to premature infants [19]; others report no difference
from those giving birth to full-term infants [20-22].
Premature birth has also been discussed as a mode of pro-
gramming for later diseases and has been compared to
programming due to undernutrition [23]. Disturbances in
FA metabolism may have long-term consequences
because FAs influence gene expression [24]. According to
Raju [25], late-preterm infants present many clinical prob-
lems, which are reflected in higher rates of rehospitaliza-
tion. The incidence of severe sequelae after preterm birth
has not decreased in recent years [26]. The long-term
problems found also in apparently healthy late premature
infants [25,27,28] have raised the question whether dif-
ferences in early development may be related to variations
in polyunsaturated fatty acids (PUFAs) in breast milk,
depending on the maternal diet. Changes in the Western
diet [14,29] and the increased demand for w3 FAs during
the perinatal period [3] may be a potential risk for subop-
timal development of infants born preterm. Most previ-
ous studies have focused on either mothers' or infants' FA
concentration in plasma, often investigating infants fed
formula with LCPUFA and using the breastfed infants as
controls.
We therefore performed an explorative study of an unse-
lected sample of breastfed preterm infants to investigate
whether it is justified to always consider breastfed infants
as controls, i.e. as gold standard. The included infants
were without severe morbidity requiring neonatal inten-
sive care, and their mothers were investigated with respect
to food intake and the concentration of FAs in breast milk
at 1 week after birth, as well as in the phospholipids of
plasma of mothers and infants at the same time, and at
ages comparable to the gestational ages of 40 and 44
weeks. This part of the investigation will address the FA
composition in infants' compared with their moth-
ers'plasma and in relation to the mothers' diet. Short- and
long-term prospective studies, including motor and men-
tal development, will be reported separately.
Subjects and methods
Subjects
Fifty-one newborn infants born prematurely after 24–36
completed weeks of gestation were consecutively included
after permission from their parents. Infants with congeni-
tal malformations or whose mothers did not speak Swed-
ish were excluded. The study comprised 23 boys and 28
girls, including eleven pairs of twins. The distribution of
gestational age and birth weight is given in Table 1. Six
infants were small for gestational age [30]. Mean (± stand-
Table 1: Distribution and mean (SD) of gestational age and birth 
weight and Apgar score in 51 preterm infants.
Gestational age, weeks 33.1 (2.6)
n (%)
24–28 wks 3 (5)
28–32 wks 10 (20)
32–36 wks 38 (75)
Birth weight, kg 2.01 (0.59)
n (%)
< 1,000 g 2 (4)
1 000–1 500 g 10 (20)
1 501–2 000 g 12 (23)
2 001–2 500 g 14 (27)
2 501–3 000 g 12 (23)
> 3 000 g 1 (2)
Apgar score at 5 min n (%)
1–3 2 (4)
4–6 5 (10)
7–10 44 (86)Lipids in Health and Disease 2009, 8:20 http://www.lipidworld.com/content/8/1/20
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ard deviation, SD) birth length was 44.5 (3.4) cm, knee-
heel distance 110.3 (9.8) mm and head circumference
31.0 (2.2) cm. Infant morbidity, including asphyxia,
mechanical ventilation for > 10 minutes, hypoglycaemia
persisting > 6 hours, convulsions, and septicaemia or
other infections, was present in 19 infants (37%). Basic
data on the mothers are given in Table 2. Morbidity
among mothers was defined as any chronic disease or
complication related to pregnancy, and was noted in 17
mothers (43%). Complicated delivery ending in vacuum
extraction or Caesarean section was reported in 21 moth-
ers. Eight mothers were cigarette smokers.
The body mass index (BMI) (kg/m2) of the mothers was
calculated from weight and height measured at a time cor-
responding to 44 weeks of gestation.
Food assessments
One week (6–10 days) after delivery the mother's food
intake was assessed using a food diary. Following detailed
instructions from the dietician the dietary intake was
recorded during 3 consecutive days including 1 weekend
day. Food content was calculated by the dietician using a
nutrition registration program (Kostplan Dietist version
2.40, Aivo AB, Sweden) and related to the Nordic Nutri-
tion Recommendations (NNRs) of 2004 [31]. After 6
months the reliability of the food assessment was tested in
25 of the 40 mothers.
Collection of samples, and lipid analyses
Breast milk
At the time of dietary recording, i.e. about 1 week after
delivery, the mothers' milk was collected over 24 hours
using an electric pump. The 24-hour sample was kept at
+4°C during collection, carefully blended and an aliquot
of 5–10 mL was frozen at -70°C until analysis of FA pat-
terns of the total lipids within 4 weeks. One hundred μL
of milk was lyophilized overnight and lipids were
extracted three times using sonication and centrifugation
at 2 000 g. Butylated hydroxytoluene (BHT) was added
(0.1 mg/mL chloroform) and the supernatant was evapo-
rated under nitrogen and redissolved in 3 mL chloroform
before methylation, as previously described [32].
Cord blood and plasma samples
Cord blood was obtained from 28 premature infants, but
only 14 of these completed the study. Blood samples were
collected from mothers and infants approximately 1 week
after delivery (range 5–12 days, "early samples"), and
again when the infants had reached the ages correspond-
ing to 40 and 44 weeks of gestation. After centrifugation
the plasma was frozen at -70°C until analysis of plasma
phospholipids. During this procedure ten plasma samples
of all those collected later were discarded accidentally.
Fatty acid analysis
Fatty acids were analysed as previously described [32].
After lipid extraction the plasma phospholipids were frac-
tionated on a single SEP-PAK aminopropyl cartridge
(Waters Corp., Milford, MA, USA) and eluated with meth-
anol after washing with chloroform:isopropanol 2:1 and
2% HAc in ether. The fraction of lipids was transmethyl-
ated in methanolic-HCL-3N at 80°C over 4 hours. The FA
methyl esters were separated by capillary gas-liquid chro-
matography in a Hewlett-Packard 6890 gas chromato-
graph. Heneicosanoic acid (21:0) was used as internal
standard and the FA methyl esters identified by compari-
son with retention times of pure reference substances
(Sigma Aldrich Sweden AB, Stockholm, Sweden). The
coefficients of variation were 1.7% for LA, 2.9% for AA
and 4.3% for DHA (n = 24).
The ratio between eicosatrienoic (mead) acid (20:3w9)
and AA, i.e. the EFA deficiency index, was used as a marker
of EFA deficiency [33].
Ethics
The study was approved by the Ethics Committee of the
Medical Faculty (the Sahlgrenska Academy) of the Univer-
sity of Göteborg, Göteborg, Sweden. Informed consent
was obtained from all mothers.
Statistical analysis
This is an exploratory study of associations between differ-
ent variables. The associations have been assessed as cor-
relations for continuous variables and mean differences
between categories, and via regression analysis. These esti-
mates have been used to indicate the size of the associa-
tions. Statistical significances (p-values) have been used to
further assess the likelihood of a true association. How-
Table 2: Distribution and mean (SD) of age, parity and body 
mass index (BMI) of the mothers (n = 40).
Age of mother (yrs) 29.8 (6.0)
n (%)
< 20 yrs 2 (5)
20–30 yrs 24 (60)
31–40 yrs 12 (30)
> 40 yrs 2 (5)
Parity n (%)
1st 19 (48)
2nd 15 (37)
3rd–4th 6 (15)
BMI (kg/m2) 24.9 (3.9)
n (%)
19–20.9 4 (10)
21–24.9 15 (38)
25–29.9 15 (38)
30–36 5 (13)Lipids in Health and Disease 2009, 8:20 http://www.lipidworld.com/content/8/1/20
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ever, because of the explorative nature of the paper, work-
ing without pre-specified hypotheses, no adjustment for
multiple testing has been done. P-values are reported and
statistical significance is stated for p < 0.05. The sample
consists partly of twins, which is important to recognize
when estimating the standard errors and calculating the
significances, therefore key results were analyzed using
both multilevel modelling and ordinary regression. No
major differences were found and ordinary regression was
then used for simplicity throughout the analysis. Means
(± standard deviation (SD)) or confidence intervals (CI)
or medians (range) are given. Multiple regressions were
constructed by the stepwise enter method based on the
significances in the simple regressions. Mean differences
between groups were calculated from independent or
paired t-tests where appropriate, otherwise by non-para-
metric tests. Pearson's correlation test was employed. Sta-
tistical calculations were computed using SPSS 14.0 (SPSS
Inc., Chicago, IL, USA).
Results
Mothers' dietary intake at 1 week
Mothers of singletons (n = 29) were compared with moth-
ers of twins (n = 11) using independent-samples t-test.
There were no significant differences in nutritional data
between the two groups.
The mean total energy intake was lower than the generally
recommended intake levels for healthy women during the
third trimester (Table 3). Thirteen mothers had an energy
intake < 2 000 kcal/day, and in nine mothers the energy
intake exceeded the recommended levels. The percentage
fat energy intake (E%) was high in 20% of the mothers;
but in five mothers the intake was < 25 E%. The ratio of
polyunsaturated to saturated fatty acids (P/S ratio)
showed a wide range with a negatively skewed distribu-
tion. The intake of monounsaturated fatty acids (MUFAs)
was below the recommended level in 17 (42%) of the
mothers, and in grams it was closely correlated to total fat
intake (r = 0.95, p < 0.0001). The dietary content of EFAs
(w6+w3 FAs) was low and was correlated to total fat
intake (E%) (r = 0.68, p < 0.0001); in 13 mothers (33%)
it was < 3 E%, and in 35 (88%) < 5 E%; none had an
intake ≥ 10 E%. Five mothers consumed < 2 E% LAs. Sig-
nificant correlations were found between E% of total fat
and LA (r = 0.66, p < 0.0001), and w3 FAs (r = 0.69, p <
0.0001). The intake of w3 PUFAs constituted < 0.5 E% in
twelve mothers (30%), while 36 (90%) consumed < 1.0
E%. A very low w3 intake (< 0.5 E%) was combined with
a low total EFA content in the diet (< 3 E%) in 11/40
mothers. The mean dietary intake (95% CI) of ALA was
1.47 g/d (1.25–1.69), and of EPA+DHA 0.20 g/d (0.13–
0.26). Also, the LA/ALA ratio, as well as the w6/w3 FA
ratio, varied without extremes, and as expected the corre-
lation between these two ratios was high (r = 0.82, p <
0.0001). Finally, the intake of vitamin E was 7.7 mg/d
(6.4–9.1); vitamin C 127 mg/d (106–148); Fe 11.0 mg/d
(9.7–12.2) and Zn 11.6 mg/d (10.7–12.5), all within the
recommended levels [31] (data not shown).
Twenty-five of the mothers agreed to repeat a 3-day food
assessment performed at home about 6 months after the
first assessment. In twelve of the 13 variables there were
no differences between the two investigations. The only
exception was a lower energy intake with a mean (± SD)
of 1 790 (400) compared with 2 250 (400) kcal/day at the
first assessment (p < 0.0001).
Table 3: Composition of macronutrients in mothers' self-reported dietary intake. 
Variable Range Mean (95% CI) NNR 2004
Energy, kcal 1382 – 3153 2266 (2119 – 2415) 2700 kcal
Carbohydrate, E% 38.3 – 74.1 55 (52.5 – 57) 55 – 60 E%
Sucrose, E% 2.8 – 22.7 12.5 (11 – 14) < 10 E%
Protein, E% 10.7 – 20.1 15 (14 – 15) 10 – 20 E%
Fat, E% 12.4 – 45.5 30 (28 – 32) 25–35 E%
SFA, E% 4.4 – 19.6 14 (13 – 14) 10 E%
Trans fat, E% 0.15 – 1.85 0.9(0.75 – 1.0) Incl in SFA
P/S ratio 0.15 – 0.63:1 0.3 (0.25 – 0.3):1 0.14 – 0.20:1
MUFA, E% 4.0 – 16.8 10 (10 – 11) 10 – 15 E%
PUFA, E% 1.7 – 7.5 4 (3 – 4) 5 E%
LA, E% 1.4 – 6.4 3 (2.5 – 3) 1.5 -4 E%
EFA w3, E% 0.3 – 1.3 0.7 (0.6 – 0.75) 1 E%
Ratio LA/ALA 2.3 – 7.5:1 5 (5 – 5.5):1 4:1
Ratio w6/w3 2.3 – 7.0:1 5 (4 – 5):1 4–5:1
A mean of 3 days, compared with the Nordic Nutrition Recommendations (NNR 2004). SFA = saturated fatty acids, MUFA = monounsaturated 
fatty acids, PUFA = polyunsaturated fatty acids, E%, percent energy of total energy in food, LA = linoleic acid, EFA = essential fatty acids, ALA = α-
linolenic acid.Lipids in Health and Disease 2009, 8:20 http://www.lipidworld.com/content/8/1/20
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Breast milk at 1 week
The premature infants were given early feeds of breast
milk from the milk bank within 1–2 hours of birth. These
were exchanged gradually with the mothers' own milk
within 3.0 (1.0) days. Thirty-six infants were exclusively
fed breast milk for between 2 weeks and 8.5 months
(median 3.0 months), while partial breastfeeding was uti-
lized in 15 infants for 1–14.5 months (median 3.0
months). Breast milk substitutes used were LCPUFA-
enriched Pre-Nan (Nestlé, Helsingborg, Sweden) and in
the older premature infants Baby-Semp 1 (Semper AB,
Stockholm, Sweden).
Twenty-eight milk samples were from mothers of single-
tons and eleven were from mothers of twins, correspond-
ing to the milk given to 50 infants (Table 4). The milk
from mothers of singletons was no different from that of
mothers of twins with the exception of palmitoleic acid
(16:1w7), which was lower in milk from mothers of twins
(p = 0.027). Trans FAs, reported as the sum of 16:1w7T
and 18:1w9T, did not exceed 4.2 mol% (mean 2.3 (1.1)
mol%). There was no significant correlation between LA
and AA, or between ALA and DHA, while EPA and DHA
were closely associated (r = 0.74, p < 0.0001). Mead acid
and AA were positively associated in breast milk (r = 0.44,
p = 0.006, n = 39).
Table 4: Composition of fatty acids (mol %) in cord blood, mothers'and infants' plasmaphospholipids and breast milk at 1 week 
postnatally.
Fatty acid Cord plasma Mothers' milk Mothers' plasma Infants' plasma Correlations, r (p)
Mean (SD) 
(n = 28)
Mean (SD) 
(n = 39)
Mean (SD) 
(n = 30)
Mean (SD) 
(n = 39)
mothers'milk – 
mo plasma 
(n = 30)
milk – infant 
early plasma 
(n = 39)
12:0 0.004 (0.01) 4.7 (2.5)§§ 0.01 (0.01)** 0.03 (0.03)¤
14:0 0.44 (0.09) 8.2 (3.0)§§ 0.52 (0.13)** 0.42 (0.13)¤¤ 0.58 (0.001) 0.36 (0.03)
16:0 35.6 (1.5) 27.4 (2.1)§§ 34.1 (1.3)** 31.5 (1.7)¤¤
18:0 13.3 (1.6) 6.8 (1.0)§§ 10.8 (1.2)** 13.8 (1.5)¤¤
Σ SFA 53.3 (1.0) 48.0 (5.7) 48.7 (0.9) 48.8 (1.3) 0.34 (0.07)
16:1w7 1.2 (0.3) 2.74 (0.59)§§ 0.72 (0.21)** 0.74 (0.29) 0.42 (0.02)
18:1w9 8.4 (1.4) 35.9 (4.1)§§ 10.0 (1.2)** 11.7 (1.1)¤¤
24:1w9 3.3 (0.4) 0.36 (0.23)§§ 3.4 (0.6)** 3.3 (0.5)
Σ MUFA 12.9 (1.9) 39.3 (4.2)§§ 14.1 (1.5)** 15.7 (1.6)¤¤
20:3w9 Mead 0.67 (0.32) 0.04 (0.02)§§ 0.25 (0.12)** 0.49 (0.27)¤¤
18:2w6 (LA) 8.1 (1.5) 9.1 (1.9)§§ 19.0 (2.3)** 15.7 (2.0)¤¤ 0.35 (0.06)
18:3w6 (GLA) 0.06 (0.03) 0.05 (0.05) 0.05 (0.03) 0.07 (0.05)¤
20:3w6 (DGLA) 5.0 (0.8) 0.43 (0.12)§§ 3.6 (0.8)** 3.5 (0.5) 0.70 (0.000) 0.36 (0.02)
20:4w6 (AA) 14.4 (2.0) 0.53 (0.09)§§ 8.0 (1.2)** 11.3 (1.6)¤¤ 0.41 (0.03) 0.46 (0.004)
Σ w6 FA 27.8 (2.0) 10.5 (2.0)§§ 30.8 (1.6)** 31.0 (2.1) 0.36 (0.05)
18:3w3 (ALA) 0.05 (0.01) 1.31 (0.40)§§ 0.35 (0.10)** 0.11 (0.03)¤¤
20:5w3 (EPA) 0.48 (0.21) 0.09 (0.03)§§ 1.07 (0.38)** 0.66 (0.19)¤¤ 0.58 (0.001) 0.68 (0.000)
22:6w3 (DHA) 4.8 (1.3) 0.45 (0.15)§§ 4.34 (1.00)** 3.3 (0.52)¤¤ 0.84 (0.000) 0.48 (0.002)
Σ w3 FA 5.3 (1.2) 1.9 (0.46)§§ 5.8 (1.15)** 4.1 (0.57)¤¤ 0.42 (0.02)
Σ PUFA 33.9 (2.1) 12.5 (2.33)§§ 40.1(1.49)** 35.5 (2.08)¤¤ 0.54 (0.002)
Ratios:
AA/DHA 3.1 (0.7) 1.3 (0.3)§§ 1.9 (0.5)** 3.5 (0.6)¤¤ 0.81 (0.000) 0.35 (0.03)
w6/w3 5.58 (1.14) 5.56 (0.94)§§ 5.58 (1.29) 7.65 (1.00)¤¤ 0.67 (0.000) 0.34 (0.03)
In mothers of twins only one value is used. Mean (SD).
The following comparisons were made by paired t-test:
 Comparison between cord plasma and early infant plasma: p < 0.000, and  p < 0.05, n = 14.
** Mothers' early plasma and breast milk: p < 0.001, n = 30.
§§ Infant early plasma and breast milk: p < 0.001, n = 39
¤¤ Mothers' plasma and infant plasma: p < 0.000, and ¤ p < 0.05, n = 38.
SFA = saturated fatty acids, MUFA = monounsaturated fatty acids, LA = linoleic acid, GLA = γ-linolenic acid, DGLA = dihomo-γ-linolenic acid, AA = 
arachidonic acid, ALA = α-linolenic acid, EPA = eicosapentaenoic acid, DHA = dococahexaenoic acid, PUFA = polyunsaturated fatty acids.Lipids in Health and Disease 2009, 8:20 http://www.lipidworld.com/content/8/1/20
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The P/S ratio in food was correlated to that in breast milk
(r = 0.74, p < 0.0001), and to the ALA (r = 0.72, p <
0.0001) and LA (r = 0.62, p < 0.0001) concentrations in
breast milk (n = 38). Significant correlations were also
found between the dietary E% of LA and the concentra-
tion of LA in breast milk (r = 0.56, p < 0.0001, n = 38),
while no correlations were found between w3 FAs, or the
LA/ALA or w6/w3 FA ratios in the food intake and breast
milk.
Cord plasma
No significant difference in plasma phospholipid concen-
tration of FAs was found between the cord blood from the
14 infants who completed the study and the group of 14
infants who did not. The two samples were therefore com-
bined (Table 4). Negative correlations were found in the
cord blood between palmitic (16:0) and stearic (18:0)
acids (r = -0.75, p < 0.0001, n = 28), and between LA and
AA (r = -0.55, p = 0.002, n = 28).
Fatty acids in the mothers' plasma at 1 week
In 30 mothers, ten of whom had given birth to twins,
blood samples for FA analyses were taken approximately
1 week after delivery (8.6 ± 2.3 days), at the same time as
breast milk was collected.
The main w6 FAs, LA and AA (Table 4), were negatively
correlated (r = -0.62, p < 0.0001, n = 30). In the w3 series,
DHA predominated, followed by EPA, and a negative cor-
relation was found between ALA and DHA (r = -0.41, p =
0.026, n = 30). The w6/w3 ratio varied from 3.4 to 9.
Mead acid showed a negative correlation to LA, and a pos-
itive correlation to AA, while no correlations were found
between mead acid and DHA or ALA in the early samples.
In the multiple regression analysis, LA and AA were both
significant contributors (β = -0.38, p = 0.032, and β =
0.42, p = 0.020, respectively; R = 0.72, R2 = 0.52, p <
0.0001, n = 30), indicating that 52% of the variation of
mead acid was explained by the concentration of these
two FAs. Docosahexaenoic acid in mothers' plasma and in
breast milk were strongly correlated (r = 0.82, p < 0.0001).
Infants' plasma fatty acids at 1 week
Blood samples were first drawn at a mean of 8.7 days after
birth (at 5–11 days in 36 infants, on day 13 in one infant,
and on day 16 in two infants). The samples from the three
older infants were not outliers for any of the FAs, and were
therefore included in the analyses (Table 4). Also the anal-
yses of FAs in the 6 SGA infants did not differ and were
therefore not separately analysed. As shown in Figures 1
and 2 the variation was large for w3 FA compared with w6
FA, especially in the mothers, and AA showed less individ-
ual variation than DHA in the infants, reflecting a strong
correlation between DHA in mothers and infants. Simi-
larly to cord blood, negative associations were found in
infants' plasma between palmitic and stearic acids (r = -
0.72, p < 0.0001), and between LA and AA (r = -0.36, p =
0.021) (n = 39). No correlation was found between ALA
and DHA.
Multiple regression analysis with mead acid as dependent
variable showed LA, AA and w3 FAs to be significant neg-
ative covariates (LA β = -0.61, p < 0.0001; AA β = -0.60, p
< 0.0001; and w3 FA β = -0.26, p = 0.030; R = 0.78, R2 =
0.60, p < 0.0001; n = 39), indicating that 40% of the vari-
ance of mead acid was explained by the concentrations of
these three components in infants' plasma. Mead acid was
independent of gestational age and birth size of the infant,
but within 10–14 days of birth the plasma concentration
had decreased markedly.
Some infants had a very low concentration of LA (< 14
mol%) in the early plasma sample (group 1, n = 9) and
were compared with the rest of the group (group 0, n =
30). The infants with low LA levels more often had high
AA (p < 0.05) and lower ALA (p = 0.001) concentrations,
but the concentration of DHA was similar. The gestational
age did not differ, but infants in group 1 were less growth
retarded (-14% versus -24%, p = 0.001) and their birth
was less complicated (p = 0.003). The mothers of group 1
had lower energy intake of total fat (p < 0.05) and MUFA
(p = 0.006). In infants' early plasma samples, lower values
were found in group 1 for all PUFA (p = 0.007), w6 FAs (p
= 0.001) and for the w6/w3 ratio (p = 0.03). That group
also had higher concentrations of palmitic (16:0) (p =
0.001), palmitoleic (16:1w7) (p = 0.002), behenic (22:0)
(p = 0.03), lignoceric (24:0) (p = 0.003) and nervonic
(24:1w9) (p = 0.02) acids, which is consistent with the
finding that the sum of saturated FAs (SFA) in infants'
early plasma was higher in group 1 (p = 0.009). Also, the
oleic (18:1w9, OA)/LA ratio was higher (p = 0.001). All
these findings indicated a higher endogenous fat synthe-
sis, probably compensating for the lower fat E% intake in
these mothers.
Comparisons between fatty acids in cord blood, and the 
relations between fatty acids in breast milk and plasma 
phospholipids of mothers and infants sampled at the same 
time
Compared with infants' plasma phospholipid FA patterns
at 1 week of age, the cord blood (n = 14) had 48% lower
concentrations of LA, but higher concentrations of
dihomo-γ-linolenic acid (DGLA, 20:3w6) and AA. The
ALA concentrations were very low; while DHA was 45%
higher in cord plasma than in infants' early plasma sam-
ples (Table 4).
Comparing cord plasma and mothers' plasma phospholi-
pid FAs at 1 week postnatally (n = 13), the former had
lower LA, but higher AA concentrations (p < 0.0001 forLipids in Health and Disease 2009, 8:20 http://www.lipidworld.com/content/8/1/20
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both). The concentrations of the w3 FAs ALA and EPA
were lower in cord plasma than in the mothers' early
plasma samples (p < 0.0001 and p = 0.001, respectively).
Docosahexaenoic acid had a similar concentration in the
two samples, explaining that the AA/DHA ratio was
higher in cord plasma (p < 0.0001). Finally, mead acid
was higher in cord plasma (p = 0.002) than in mothers'
early plasma samples, but showed no correlation to either
w6 or w3 FAs.
The FA composition of plasma phospholipids showed
major similarities between mother and infant at 1 week of
age although the difference between the samples was sig-
nificant, especially for LA and the w3 FAs, which all
showed higher concentrations in mothers' plasma. There
were few significant correlations between mothers' and
infants' plasma except for the w3 FAs ALA (r = 0.53, p =
0.001), EPA (r = 0.49, p = 0.002) and DHA (r = 0.37, p =
0.022) (n = 38).
The composition of breast milk is the major determinant
of the infant's plasma FA concentrations after birth, and
we therefore compared the different compartments
although the difference in their type has to be considered
and consequently the results need to be evaluated with
caution. The total concentration of SFA in breast milk was
similar to that of mothers' plasma phospholipids (Table
4), but with higher concentrations of lauric (12:0) and
myristic (14:0) acids and lower concentration of palmitic
and stearic acids, also in relation to the infants' plasma
phospholipids analysed at the same time. The biological
significance of the high amount of these shorter FAs in
breast milk has not been explored. There was a marked
increase in OA and palmitoleic (16:1w7) acids, but not in
Linoleic (18:2w6) and arachidonic (20:4w6) acid in serum phospholipids of mothers and their premature infants from 1 week  after birth to 44 weeks of gestational age Figure 1
Linoleic (18:2w6) and arachidonic (20:4w6) acid in serum phospholipids of mothers and their premature 
infants from 1 week after birth to 44 weeks of gestational age.Lipids in Health and Disease 2009, 8:20 http://www.lipidworld.com/content/8/1/20
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nervonic acid (24:1w9) in mothers' milk compared with
infants' plasma. The ratio of OA/LA was also substantially
higher in mothers' milk than in plasma (p < 0.0001). The
concentrations of the w6 FA LA, and especially DGLA and
AA, were substantially lower (total about 66%) than in
mothers' and infants' plasma phospholipids. The w3 FAs
likewise showed similar lower concentrations in mothers'
milk than in plasma, except for ALA, which was three
times and twelve times higher than in mothers' and
infants' plasma, respectively. A close correlation was
found between DHA as well as EPA in mothers' plasma
and milk (Table 4). Mead acid was lower in breast milk
compared with mothers' plasma, while the EFA deficiency
index was higher (Figure 3). A significant correlation was
found between AA in mothers' milk and infants' plasma
and between EPA and DHA in mothers' milk and infants'
plasma, but not for LA or ALA (Table 4).
In order to investigate whether some factors would be
identified to predict the concentration of w6 and w3 FAs
in mothers' milk, and in infants' early plasma samples, the
concentrations of w6 and w3 in breast milk were tested for
possible correlations with background factors, viz. moth-
ers' food and mothers' plasma. The w6 FAs in breast milk
were best predicted by the P/S ratio in food, and the PUFA
concentration in mothers' plasma (β = 0.58, p < 0.0001,
and β = 0.31, p = 0.039, respectively; R = 0.76, R2 = 0.58,
p < 0.0001, n = 29). Seventy-two per cent of the w3 FA
concentration in breast milk was explained by three fac-
tors, namely the P/S ratio in mothers' food (β = 0.66, p <
0.0001), the sum of w3 FAs in mothers' plasma at the
same time (β = 0.42, p = 0.001), and gestational age
(days) (β = 0.28, p = 0.016; R = 0.85, R2 = 0.72, p < 0.0001,
n = 29). No PUFA in mothers' diet correlated significantly
to predict w6 in infants' plasma from background factors,
Alpha-linolenic (18:3w3) and docosahexaenoic (22:6w3) acids in serum phospholipids of mothers and their premature infants  from 1 week after birth to 44 weeks of gestational age Figure 2
Alpha-linolenic (18:3w3) and docosahexaenoic (22:6w3) acids in serum phospholipids of mothers and their pre-
mature infants from 1 week after birth to 44 weeks of gestational age.Lipids in Health and Disease 2009, 8:20 http://www.lipidworld.com/content/8/1/20
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mothers' plasma and breast milk. On the other hand, the
w3 FA concentration in infants' plasma was predicted by
two factors: DHA in breast milk (β = 0.51, p < 0.0001) and
the OA/LA ratio in mothers' plasma (β = -0.28, p = 0.045;
R = 0.63, R2 = 0.40, p < 0.0001, n = 38). The analyses
therefore indicated that the P/S ratio in mothers' food
intake and their intake of w3 FAs accounted for about
40% of the variance of EFAs in infants' early plasma sam-
ples.
Longitudinal study of mothers' plasma fatty acids up to 44 
weeks
Comparisons of mothers' early plasma sample and the
samples of infants corresponding to a gestational age of
40 weeks showed increases in LA (p < 0.0001) and the AA/
DHA ratio (p < 0.0001, n = 31). Docosahexaenoic acid
levels decreased with time (p < 0.0001, n = 31), but
showed great individual variation, as did the ALA concen-
tration (Figure 2). Also, the w6/w3 and LA/ALA ratios
increased significantly between the early samples and
those corresponding to the gestational age of 44 weeks (n
= 32, p < 0.0001 for both). No difference was detected in
mothers' plasma between 40 and 44 weeks for any FA
Box plot of the essential fatty acid (EFA) deficiency index (the mead acid 20:3w9/arachidonic acid 20:4w6 ratio) in breast milk  (unfilled) and in mothers' (M, grey) and infants' (I, dotted) plasma phospholipids from 1 week of age (early) to 44 weeks of ges- tational age Figure 3
Box plot of the essential fatty acid (EFA) deficiency index (the mead acid 20:3w9/arachidonic acid 20:4w6 
ratio) in breast milk (unfilled) and in mothers' (M, grey) and infants' (I, dotted) plasma phospholipids from 1 
week of age (early) to 44 weeks of gestational age. The boxes indicate medians and 25th–75th percentiles. Whiskers indi-
cate 5th to 95th percentiles and outliers are indicated by separate symbols.Lipids in Health and Disease 2009, 8:20 http://www.lipidworld.com/content/8/1/20
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except EPA (Table 5). The variability of w3 FAs was much
larger than that of w6 FAs in the mothers. Strong correla-
tions were found for most FAs measured at 40 and 44
weeks. At 40 weeks, > 60% of the results for mead acid
were explained by two negative covariates, LA and DHA,
which was even more pronounced at 44 weeks (LA β = -
0.67, p < 0.0001; DHA β = -0.63, p < 0.0001; R = 0.80, R2
= 0.64, p < 0.0001, n = 27).
Longitudinal study of infants' plasma fatty acid levels up to 
44 weeks
Comparisons between infants' early plasma samples and
samples obtained corresponding to 40 and 44 weeks of
gestational age showed strong significant increases of
mean LA and ALA values compared with early samples.
The ratio of these two variables did not change, while the
total w6/w3 ratio increased slightly (p = 0.020, n = 30).
The concentration of AA had decreased by 40 weeks (p <
0.0001, n = 30), and the negative correlation between LA
and AA was strong (r = – 0.87, p < 0.0001, n = 36). In con-
trast to early infants' plasma also the correlation between
ALA and DHA was significant (r = -0.39, p = 0.018, n =
36). At 44 weeks the correlation between LA and AA had
strengthened (r = -0.94, p < 0.0001, n = 45), but that
between ALA and DHA was no longer significant (p =
0.093). Therefore the increased intake of LA with age
seemed to inhibit the AA synthesis, but a similar associa-
tion with time was not found for ALA and DHA. For this
time period, DHA was not significantly changed, although
some initial high values had decreased markedly (Figure
2). The AA/DHA ratio had decreased (p < 0.0001, n = 30),
supporting an inverse association between LA and AA.
Mead acid and the EFA deficiency index were both lower
at 40 weeks (p < 0.0001, n = 30) (Figure 3), and signifi-
Table 5: Serum phospholipid fatty acids (mol %) in mothers' and infants' plasma at 40 and 44 week.
Fatty acid Mothers' plasma 
at 40 w 
(n = 29)
Mothers' plasma 
at 44 w 
(n = 29)
r (p) mothers 
40 and 44 w 
(n = 29)
Infants' plasma 
at 40 w 
(n = 36)
Infants' plasma 
at 44 w 
(n = 45)
r (p) infants 
40 and 44 w 
(n = 36)
12:0 0.02 (0.01) 0.02 (0.01) 0.66 (0.000) 0.03 (0.02) 0.03 (0.02) 0.55 (0.000)
14:0 0.49 (0.13) 0.45 (0.11) 0.57 (0.001) 0.44 (0.11) 0.38 (0.10)§ 0.52 (0.001)
16:0 32.1 (1.17) 31.6 (1.29) 0.61 (0.001) 28.5 (1.16) 28.9 (1.43)§ 0.78 (0.000)
18:0 12.3 (1.19) 12.4 (0.91) 0.78 (0.000) 16.2 (1.14) 15.9 (1.21)§ 0.73 (0.000)
Σ SFA 48.3 (0.69) 47.9 (1.10) 0.63 (0.000) 48.2 (0.77) 48.3 (0.89) 0.29 (0.140)
16:1w7 0.70 (0.19) 0.58 (0.16) 0.46 (0.012) 0.40 (0.08) 0.35 (0.08)§§ 0.82 (0.000)
18:1w9 10.2 (1.17) 10.0 (0.99) 0.62 (0.000) 11.2 (0.75) 11.0 (0.94) 0.54 (0.001)
24:1w9 2.98 (0.40) 3.00 (0.42) 0.67 (0.000) 2.81 (0.49) 2.67 (0.47)§ 0.50 (0.002)
Σ MUFA 13.8 (1.41) 13.6 (1.04) 0.75 (0.000) 14.4 (0.86) 14.0 (0.82)§ 0.52 (0.001)
20:3w9 Mead 0.22 (0.09) 0.21 (0.09) 0.69 (0.000) 0.16 (0.06) 0.14 (0.04)§ 0.75 (0.000)
18:2w6 (LA) 21.6 (1.47) 22.0 (2.29) 0.38 (0.045) 20.9 (2.47) 22.0 (2.74)§ 0.68 (0.000)
18:3w6 (GLA) 0.08 (0.05) 0.08 (0.05) 0.68 (0.000) 0.05 (0.02) 0.04 (0.02) 0.67 (0.000)
20:3w6(DGLA) 3.14 (0.56) 2.98 (0.70) 0.75 (0.000) 2.99 (0.55) 2.79 (0.57)§ 0.68 (0.000)
20:4w6 (AA)  7.8 (1.02) 8.0 (1.21) 0.82 (0.000) 8.75 (1.65) 8.4 (1.80) 0.79 (0.000)
Σ w6 FA 32.9 (1.53) 33.3 (1.84) 0.50 (0.006) 33.0 (1.06) 33.6 (1.02)§ 0.29 (0.092)
18:3w3 (ALA) 0.32 (0.10) 0.32 (0.10) 0.67 (0.000) 0.15 (0.03) 0.17 (0.04)§ 0.60 (0.000)
20:5w3 (EPA) 1.21 (0.34) 1.35(0.38)* 0.70 (0.000) 0.61 (0.25) 0.53 (0.32) 0.79 (0.000)
22:6w3 DHA 3.25 (0.88) 3.31 (1.09) 0.76 (0.000) 3.40 (0.73) 3.43 (0.97) 0.73 (0.000)
Σ w3 FA 4.8 (0.96) 5.0 (1.23) 0.68 (0.000) 4.2 (0.85) 4.1 (1.18) 0.73 (0.000)
Σ PUFA 37.9 (1.50) 38.5 (1.37) 0.57 (0.001) 37.4 (1.16) 37.8 (0.93)§ 0.60 (0.000)
Ratios:
AA/DHA 2.6 (0.86) 2.7 (1.12) 0.88 (0.000) 2.7 (0.62) 2.6 (0.58)§ 0.83 (0.000)
w6/w3 7.1 (1.50) 7.13 (1.99) 0.58 (0.001) 8.3 (1.94) 8.9 (2.96) 0.71 (0.000)
In mothers of twins only one value is given. Mean (SD). For abbreviations see table 4.
Pearson correlation coefficients. Paired t-test was used for testing differences between 40 and 44 weeks, for mothers * p < 0.05 (n = 29) and for 
infants §p < 0.05, §§ p < 0.001 (n = 36).Lipids in Health and Disease 2009, 8:20 http://www.lipidworld.com/content/8/1/20
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cantly lower than in the corresponding mothers' plasma
(p < 0.0001). Also, the OA/LA ratio had decreased (p <
0.0001, n = 30).
Between 40 and 44 weeks LA and ALA increased further
without changes to their ratio (Table 5). The concentra-
tions of AA and DHA were similar. At 44 weeks, mead acid
had decreased and no correlation was found to the main
w6 or w3 FAs. The wide variations in the infants' early
samples were in contrast to the much smaller variation at
40 and 44 weeks of gestational age (Figures 1 and 2).
Comparison of the major w3 FAs in infants' and mothers'
plasma phospholipids showed a similar decreasing pat-
tern for DHA as for AA, but a markedly smaller variation
in ALA compared with LA over time in the infants. The
development of the w6/w3 ratio in mothers and infants
with gestational age is shown in Tables 4 and 5. The EFA
deficiency index (Figure 3) decreased in a similar pattern
as mead acid (20:3w9), palmitoleic acid (16:1w7) and the
OA/LA ratio (data not shown).
The influence of breastfeeding on infants' and mothers' 
fatty acid pattern
The feeding of the infants during the first period of life sig-
nificantly influenced their plasma phospholipid FA pat-
tern. Plasma from infants who had been fed mothers'
milk until up to 44 weeks' gestational age, group L ("long
breastfeeding") (n = 38), were compared with infants who
had stopped breastfeeding at any time before 44 weeks,
group S ("short breastfeeding") (n = 7). The w6/w3 ratio
in breast milk and in early infants' plasma samples did not
differ between the two groups, the latter being 7.6 and 7.9
in groups L and S, respectively (p = 0.21). At 40 weeks the
ratio differed significantly (p = 0.003) and it differed even
more at 44 weeks (p < 0.0001) (Figure 4). In group L the
DHA level in infants' plasma in fact increased between 1
week of age and 44 weeks of gestational age (p = 0.018)
(Figure 5), and despite an increase in w6 FA, the w6/w3
ratio at 44 weeks had not changed. Contrary to this, the
EPA and DHA plasma concentrations fell considerably in
the infants of group S (p < 0.0001) (Figure 5), while ALA
was equal in the two groups. Infants in group S also had a
lower AA concentration (p < 0.0001), and a higher con-
centration of LA (p < 0.0001) than group L at the age cor-
responding to 44 weeks of gestation.
Mothers of infants in group L had decreasing DHA plasma
concentrations, especially between 1 week postnatal and
the expected time of birth (40 weeks), and no difference
was found between mothers and infants at 44 weeks. At
the same time the ALA concentration in mothers' plasma
was approximately twice as high as that in the infants'
plasma (p < 0.0001). The AA concentration was relatively
constant over time, but significantly lower than in the
infants (p = 0.006), while LA did not differ. In the mothers
of group S, the plasma concentrations of DHA and w3 FAs
showed a restitution between week 40 and week 44, and
the w6/w3 ratio decreased during the same period of time.
Corresponding to the gestational age of 44 weeks, DHA
and w3 FAs were higher and the w6/w3 ratio was lower in
mothers than in the infants of group S (p < 0.0001). Mead
acid was higher in mothers' than in infants' plasma at 44
weeks (p < 0.0001) (Table 5). Both at 40 and at 44 weeks,
mead acid had significant negative correlations to LA and
DHA in mothers' plasma. In the mothers of group L, mead
acid in plasma was predicted by the LA concentration (β =
-0.74, p < 0.0001), and DHA (β = -0.69, p < 0.0001; R =
0.84, R2 = 0.71, p < 0.0001, n = 32), indicating that these
FAs explained 70% of the variance in the mead acid con-
centration.
Mothers of group L (n = 31) had a lower energy intake of
fat (p = 0.02), including SFA (p = 0.04) and MUFA (p =
0.015), but a higher intake of carbohydrates (p = 0.02)
than mothers of group S (n = 9). There were no differences
The ratio of the sum of w6/w3 fatty acid concentrations  (FAs) in infants' plasma phospholipids at 1 week of age (early)  and at the gestational ages of 40 and 44 weeks Figure 4
The ratio of the sum of w6/w3 fatty acid concentra-
tions (FAs) in infants' plasma phospholipids at 1 week 
of age (early) and at the gestational ages of 40 and 44 
weeks. Infants, whose mothers stopped breastfeeding during 
the observation period (black squares), and infants, whose 
mothers were still breastfeeding at 44 weeks (black circles) 
are indicated. Data are given as means with 95% confidence 
intervals.
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between these groups for the P/S ratio or dietary intake of
w6 and w3 FAs or the w6/w3 ratio in breast milk. The
mothers of group L had a lower BMI (p = 0.007) and a
higher educational status (p = 0.002) and more rarely
smoked cigarettes (p = 0.01). There were no differences
between the groups regarding gestational length, delivery,
neonatal morbidity, sex, parity, birth weight, or size of the
infants. The multiple logistic regression analysis indicated
that smoking was the strongest predictor of shortness of
breastfeeding (odds ratio, OR = 33.2, CI 11.0–100.3). The
mothers' education also had a strong impact (lowest cate-
gory OR = 20.4, CI 5.0–82.9, and intermediate education
OR = 2.1, CI 0.64–7.0, compared with highest education,
i.e. university). Furthermore, a higher BMI (OR = 1.6, CI
1.32–1.98) also independently predicted shorter breast-
feeding.
Discussion
This study presents a comprehensive prospective explora-
tion of the associations between mothers' food intake,
breast milk and plasma FA patterns early after birth up to
the age corresponding to 44 weeks of gestation in mothers
and their premature infants. The study forms the basis for
further, ongoing longitudinal long-term follow-up stud-
ies. The initial large interindividual variation in EFAs in
infants' plasma persisted during this early period of life
although the pattern of increasing concentrations of LA
and ALA and the relatively stable or decreasing concentra-
tions of DHA and AA were clearly visible (Figures 1 and
2). The variability of FA concentrations in the mothers'
plasma was much lower than in the infants for LA and AA,
but not for ALA and DHA. Of special interest was the
impact of breastfeeding on both infants' and mothers'
plasma FA concentrations during the early postnatal
period, indicating that the supply of LCPUFA-enriched
formula milk cannot fully compensate for breastfeeding.
This suggests that premature infants may be at special risk
if not supplied with breast milk from their mothers (Fig-
ures 4 and 5).
Impact of the mothers' diet
The mothers' diet had a relatively low energy content and,
in a majority of the cases, a low content of EFAs both of
the w6 and of the w3 series. It has been argued previously
that low intake of w3 may contribute to premature birth
[34], which would be supported by our study, since most
mothers had w3 intake below recommended levels. It
may be argued that the food composition did not mirror
the usual food composition of the women, because the
food intake records were done when most women were
still in the hospital and under stress. However, when the
dietary assessment was repeated 6 months later the results
were not significantly different, except that the energy
intake was 20% lower than at the first recording. This indi-
cates that it is unlikely that the energy intake was underre-
ported at the first investigation. The strong correlations
between dietary factors and infants' FA concentrations
suggest that more attention should be directed towards
mothers' food intake during pregnancy. Dietary intake of
both LA and ALA was strongly correlated to the total
intake of fat (E %), but in breast milk only LA was associ-
ated with the mother's dietary intake, probably because
ALA is considered to be oxidized to a greater extent [35].
This may be cause for concern since it has been suggested
that at low fat and energy intake, more EFAs may be β-oxi-
dized [36], which would further increase the risk that the
infant may get an insufficient supply of EFAs in the breast
milk. Mothers in this study, with the most "ideal" diet
according to general recommendations (i.e. a low fat-high
carbohydrate intake) also gave birth early to infants with
the lowest LA concentrations. Our results suggest a risk
that recommendations of low fat intake during pregnancy
Docosahexaenoic acid (DHA) (22:6w3, unfilled symbols) and  eicosapentaenoic acid (20:5w3, filled symbols)concentra- tions in infants' plasma phospholipids at 1 week of age (early)  and at the gestational ages of 40 and 44 weeks Figure 5
Docosahexaenoic acid (DHA) (22:6w3, unfilled sym-
bols) and eicosapentaenoic acid (20:5w3, filled sym-
bols)concentrations in infants' plasma phospholipids 
at 1 week of age (early) and at the gestational ages of 
40 and 44 weeks.(squares) infants whose mothers stopped 
breastfeeding during the observation period, (circles) infants 
whose mothers were still breastfeeding at 44 weeks. Data 
are given as means with 95% confidence intervals.
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may negatively affect the supply of EFAs to the foetus and
infant, which may not be possible to restore later in life
and may have negative consequences for future health
[37]. Linoleic acid as well as ALA in the breast milk was
predicted by the P/S ratio of the mothers' dietary intake
and to some extent by the PUFA level in the mothers'
plasma. This confirms earlier observations that both diet
and mobilization of fat reserves are important for breast
milk composition [9].
The impact of placental transfer compared with breast 
milk
As expected, LCPUFAs were found to predominate in the
cord plasma. By comparison, the concentrations of AA
and DHA were relatively low in mothers' milk, where LA
and ALA dominated, which raises concerns about whether
the large need of LCPUFAs, especially DHA, can always be
satisfied by breastfeeding in prematurely born infants.
Previous studies report a much higher concentration of
LCPUFAs in breast milk [12,14]. The difference between
cord blood and infants' early plasma samples indicated a
much more efficient transfer of LCPUFAs via the placenta
than through breast milk. The variation in early plasma
samples from the infants was large for these more impor-
tant LCPUFAs, with AA ranging from 8 to 19 mol% and
DHA from 2.5 to 7 mol%. The concentrations were not
associated with gestational age or birth weight and there-
fore probably reflected the different status of the mothers.
A minor part may also be associated with different capac-
ity in the newborns to transform EFAs to LCPUFAs [38-
41].
The impact of breastfeeding and mothers' fatty acid status
The concentrations of AA and DHA, but not of LA and
ALA, showed a positive correlation between breast milk
and infants' plasma. On the other hand, correlation
between mothers' and infants' early plasma samples could
only be found for ALA, EPA and DHA. This may be due to
fast conversion of LA to AA. This changes with time, since
at 40–44 weeks the high LA concentrations seemed to
decrease the transformation to AA [35], as supported by
the decreased AA/DHA ratio despite unchanged DHA con-
centrations. This interpretation was also supported by the
findings in the group showing very low initial LA concen-
trations and significantly higher AA concentrations in
infants' plasma. Interestingly, these infants differed in
length, supporting earlier findings that AA is important
for growth [42]. High concentrations of LA may inhibit
the  Δ6 desaturase activity and would thus explain the
inverse association between LA and AA [43].
The DHA and EPA levels in mothers' plasma were closely
correlated to these levels in both breast milk and infants'
plasma, corroborating results from intervention studies
by Innis [14]. Gestational age was another significant cov-
ariate, pointing to the importance of increasing mothers'
intake and/or storage of w3 FAs with time [5,44]. The
close correlations between mothers' plasma and breast
milk obtained at the same time indicated less influence of
the mammary gland on the FA pattern. In rats, mammary
glands have been shown to contain Δ5 and Δ6 desatu-
rases, which are stimulated by a diet low in w6 FAs [45],
probably to uphold the synthesis of AA, indicating the
biological importance of keeping the balance of the very
important systems of prostanoid precursors (cf 44). The
infants with very low LA concentration in plasma at 1
week of age had higher AA concentrations, which would
support this feedback system, although we could not eval-
uate whether this was related to enzyme systems in the
infants or in the mothers.
Mead acid, an indicator of essential fatty acid deficiency
Although the mothers had a relatively low EFA intake, the
plasma phospholipids pattern of FAs did not indicate a
real deficiency. Nevertheless, mead acid in cord blood was
very high and indicated a relative deficiency, probably
associated with the demands of the foetus during preg-
nancy [5]. High concentrations of mead acid in pregnancy
have previously been observed [46,47]. In our group of
mothers these concentrations decreased rapidly after
birth, but increased later again in those mothers who con-
tinued breastfeeding. They decreased faster and continu-
ously in the infants and could hardly be detected after 40
weeks of gestational age. This may indicate that also in
newborns mead acid is mainly associated with the w6
series of FAs, and that it is a sensitive marker of insuffi-
cient EFA supply also at this age. Mead acid has been pro-
posed to be a substitute for AA in biological membranes
because of similar biochemical structure, and therefore
the mead acid/AA ratio has been used as an index of EFA
deficiency. The often markedly increased mead acid in the
early infants' plasma samples was associated with low
plasma concentrations of LA and AA, but multiple regres-
sion analyses have indicated that mead acid was also asso-
ciated with w3 FA concentrations. It is tempting to
speculate whether the high concentration of mead acid in
cord blood and in infants' early plasma samples may indi-
cate a special function of this FA during foetal life.
The impact of breastfeeding up to 40–44 weeks gestational 
age
Breastfeeding mothers offer compensatory protection to
their premature infants through the breast milk, especially
concerning DHA content in the short time up to 44 weeks
of gestational age. The major group of mothers who were
breastfeeding to 44 weeks (group L) showed successively
decreasing plasma levels of DHA, while their infants had
significantly increased their plasma level at 44 weeks com-
pared with their initial values (Figure 5). The decreasing
DHA concentrations in the lactating mothers may supportLipids in Health and Disease 2009, 8:20 http://www.lipidworld.com/content/8/1/20
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the observation by Al et al. [48], that mothers are at risk
for subsequent DHA depletion by many pregnancies.
Also, the concentration of AA in group L at 44 weeks was
higher in the infants than in their mothers, indicating that
both these LCPUFAs were selectively enriched in infants'
plasma. In the small group of mothers with short breast-
feeding (group S), DHA levels increased between 40 and
44 weeks, and the w6/w3 ratio decreased, indicating that
DHA was retained. Correspondingly, in the infants of this
group a marked fall of both DHA and AA was seen in
plasma, despite the fact that the infants were supplied
with LCPUFA-enriched breast milk substitutes. The influ-
ence of other risk factors identified in this group of moth-
ers must therefore be considered, especially smoking,
which was more common in the mothers with short
breastfeeding. Since maternal smoking has been shown to
impair DHA synthesis [49], insignificantly lower DHA
levels already in the early plasma samples in the group of
smoking mothers may support such association. These
observations further stress the need for supplementation
with LCPUFA during pregnancy [50].
Between 40 and 44 weeks of gestational age, the DGLA
and AA concentrations in the infants were already similar
to those in the mothers, but the w3 FAs, especially ALA
and EPA, were still lower while the DHA concentration
was similar. Since others have shown that the LCPUFA
content decreases from birth to mature milk in both term
and preterm infants [12,51], the results may indicate that
newborn premature infants have a fairly good capacity to
synthesize LCPUFA [38].
The steadily increasing w6/w3 ratio in infants not breast-
fed up to week 44 was probably related to the higher w6/
w3 ratio in formula, which has been recommended to
range from 8 to 9[52], compared with breast milk which
in our study averaged 5.6. It was obvious that formula
feeding influenced the FA pattern in infants, with a rapidly
increasing w6/w3 ratio and decreasing AA and DHA con-
centrations. A special concern is that mothers have been
warned not to eat fish due to environmental pollution.
Such warning may result in a too low fish intake, as indi-
cated by the food records and also described by others
[50].
In summary, this study shows that a majority of unselected
mothers of late premature infants in an ordinary urban
setting in Sweden had a low energy and PUFA intake, and
especially a low intake of w3 FAs, which was reflected in a
wide range of w3 FA concentrations in infants' early
plasma samples. Some infants born to mothers who
reported having strictly kept to the nutritional recommen-
dations, had extremely low LA concentrations at an early
age. Infants of mothers, who continued breastfeeding up
to the age corresponding to 44 weeks of gestation, kept
their w3 FA concentrations in plasma, but those who did
not fully breastfeed had rapidly decreasing concentrations
and, simultaneously, markedly increased w6/w3 FA ratios
in their plasma. Our study indicates that EFAs, and espe-
cially w3 FAs, may be unsatisfactorily supplied to preg-
nant mothers. In the context of the importance of
satisfactory supplementation of LCPUFAs during this
early period of life, controlled randomized intervention
studies, starting early in pregnancy with long-term follow-
up, are urgently needed.
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